All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the International Myeloma Foundation or Myeloma crowd.
Vaccines aim to activate a specific immune response and various peptide/protein vaccines are currently under investigation for tumor treatment. Examples include peptides derived from myeloma-associated antigens, such as mutant Wilms tumor 1 (WT 1), X-box binding protein 1 (XBP1), syndecan-1 (CD138), and CS1 (CD319).